Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.47 | 14514962 15322242 11752688 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.64 | 17418594 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
4.01 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
5.05 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.34 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.47 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.51 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
3.00 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.42 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.29 | 11985600 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.20 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.91 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.91 | 16595493 15939500 18628466 19526202 18234424 17426702 16096432 16264153 15692762 15567936 15634643 16935488 16115903 18382427 15668708 18695136 17983394 15136595 17369602 16322301 15994142 15993339 11325840 16826403 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.91 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.53 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.12 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
2.26 | 18059187 16234567 16023760 17876044 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.62 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.31 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.72 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.56 | 18850075 16120746 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.77 | 16269455 16242529 16651473 16455267 16952015 17519947 15505089 17924179 16109756 16612575 16731534 17974986 15792986 16364871 15811867 17007740 17308081 17382496 17131338 17329180 17928571 16278810 18627295 15476868 17351982 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.05 | 16243910 17334414 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.98 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.24 | 8697196 16354765 15340226 15668235 12621046 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.15 | 18802399 18259882 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.43 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.27 | 10048152 20055451 15322242 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.74 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
4.18 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.18 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
9.10 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
9.10 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.80 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.62 | 16714409 15322242 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.69 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.42 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.88 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.15 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
4.02 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
5.22 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.51 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.59 | 17150277 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.32 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.78 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.51 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.75 | 16244371 14766674 17888722 16879835 16330681 17875725 12587719 16244372 16707910 18006777 16144979 16495754 18674790 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.56 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.33 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.76 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.45 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.77 | 17606976 18501091 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.77 | 16354765 15340226 16959395 18606429 8697196 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.02 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
2.03 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.53 | 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.76 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.25 | 15369732 15699352 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.58 | 16707910 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.88 | 16085563 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.52 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.52 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.83 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.67 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.67 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.49 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.49 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.73 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.13 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
5.13 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.26 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.33 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.18 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.93 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.42 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.08 | 19429709 15857846 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.34 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.08 | 18259882 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.33 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.37 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
11.32 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
11.32 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.43 | 15555623 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.44 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.62 | 11985600 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.97 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.88 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.88 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
4.07 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
11.70 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
11.70 | 11399792 11118676 11222880 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.63 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.36 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.36 | 16868541 15897917 18437689 15749863 16729912 16888761 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.42 | 10548101 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.78 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.35 | 18990726 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.38 | 15625365 16767912 15675481 17710206 18313854 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.75 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.42 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
6.22 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.22 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
5.13 | 15625365 16767912 17203757 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.61 | 16684133 16045194 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.62 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.67 | 16010429 17909728 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.88 | 17653716 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.73 | 14652134 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.32 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.78 | 17638931 16364871 17678736 17334414 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.97 | 15886252 |